FDA
-
-
-
-
-
-
-
ANI Pharmaceuticals gets FDA approval for generic everolimus suspension
-
-
-
-
-
-
-
ANI Pharmaceuticals eye implant trial meets both primary endpoints
-
-
-
-
-
-
-
ANI Pharmaceuticals launches generic isosorbide mononitrate tablets
-
-
-
-
-
-
-
ANI Pharmaceuticals projects 2026 revenue to exceed $1 billion
-
-
-
-
-
-
-
ANI Pharmaceuticals NEW DAY trial results to be presented at AAO 2025
-
-
-
-
-
-
-
ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIENĀ® for Use in Patients with Diabetic Macular Edema (DME)
-
-
-
-
-
-
-
ANI Pharma (ANIP) Announces Buyout of Royalty Obligation for ILUVIEN and YUTIQ
-
335,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


